PubRank
Search
About
Malcolm V Brock
Author PubWeight™ 75.02
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
PLoS Med
2006
5.80
2
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
Nat Genet
2012
4.70
3
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.
Cancer Discov
2011
4.60
4
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.
Cancer Cell
2012
3.82
5
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.
Mol Cancer Res
2006
3.72
6
Elevated incidence of lung cancer among HIV-infected individuals.
J Clin Oncol
2006
2.46
7
Epidemiology of lung cancer: looking to the future.
J Clin Oncol
2005
2.33
8
Promoter hypermethylation of resected bronchial margins: a field defect of changes?
Clin Cancer Res
2004
1.93
9
Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.
Clin Cancer Res
2012
1.80
10
Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Chest
2013
1.77
11
Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging.
Ann Thorac Surg
2012
1.69
12
The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence?
J Thorac Cardiovasc Surg
2009
1.55
13
Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
Cancer Res
2009
1.55
14
Time for oncologists to opt in for routine opt-out HIV testing?
JAMA
2010
1.53
15
Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
J Thorac Cardiovasc Surg
2002
1.46
16
Hypermethylation of the GATA genes in lung cancer.
Clin Cancer Res
2004
1.45
17
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Oncotarget
2013
1.44
18
The use of "overall accuracy" to evaluate the validity of screening or diagnostic tests.
J Gen Intern Med
2004
1.41
19
Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?
J Thorac Cardiovasc Surg
2009
1.27
20
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus.
Clin Cancer Res
2006
1.26
21
Are surgical outcomes for lung cancer resections improved at teaching hospitals?
Ann Thorac Surg
2008
1.23
22
Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.
Cancer Res
2006
1.12
23
Hypermethylation of the GATA gene family in esophageal cancer.
Int J Cancer
2006
1.12
24
Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.
J Pathol
2013
1.09
25
Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.
Epigenetics
2008
1.08
26
Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy.
J Am Chem Soc
2010
1.05
27
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies.
Oncogene
2005
0.99
28
Methylation of TFPI-2 is an early event of esophageal carcinogenesis.
Epigenomics
2012
0.95
29
SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.
Discov Med
2012
0.93
30
Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer.
Int J Cancer
2007
0.93
31
Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer.
Int J Cancer
2005
0.92
32
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.
Ann Thorac Surg
2012
0.90
33
Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
J Mol Diagn
2012
0.90
34
Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Chest
2010
0.89
35
Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
Discov Med
2013
0.89
36
Enzymatic incorporation of multiple dyes for increased sensitivity in QD-FRET sensing for DNA methylation detection.
Chembiochem
2010
0.87
37
Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling.
J Cell Mol Med
2014
0.87
38
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events.
Clin Chim Acta
2013
0.87
39
Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Gastric Cancer
2014
0.86
40
Glutamate excitotoxicity mediates neuronal apoptosis after hypothermic circulatory arrest.
Ann Thorac Surg
2010
0.85
41
Invited commentary: the etiology of lung cancer in men compared with women.
Am J Epidemiol
2013
0.85
42
Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior.
J Gastrointest Surg
2003
0.84
43
Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.
Clin Cancer Res
2014
0.83
44
A murine xenograft model of spontaneous metastases of human lung adenocarcinoma.
J Surg Res
2011
0.82
45
Epigenetic changes associated with neoplasms of the exocrine and endocrine pancreas.
Discov Med
2014
0.81
46
A handy tool to teach segmental liver anatomy to surgical trainees.
Arch Surg
2012
0.81
47
Epigenetic changes and functional study of HOXA11 in human gastric cancer.
Epigenomics
2015
0.81
48
Impact of elastic staining on the staging of peripheral lung cancers.
Am J Surg Pathol
2007
0.80
49
Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers.
J Thorac Oncol
2014
0.78
50
A case of ectopic parathyroid hormone production by a pulmonary neoplasm.
J Thorac Cardiovasc Surg
2006
0.77
51
CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.
Cancer Biol Ther
2012
0.77
52
Lung cancer: new surgical approaches.
Respirology
2007
0.75
53
Aortic and mitral valve disruption following nonpenetrating chest trauma.
J Trauma
2002
0.75